EP1370316A1 — Fluid filled ampoules and methods for their use in aerosolizers
Assigned to Novartis AG · Expires 2003-12-17 · 22y expired
What this patent protects
An ampoule (10) designed for holding fluid and adapted for use in an aerosolization device having two opposing ends (14 & 16) and a sealed interior (18). One end (14) having a movable shroud (24) and removable tab (22) for creating a drain vent and an opposing end (16) having…
USPTO Abstract
An ampoule (10) designed for holding fluid and adapted for use in an aerosolization device having two opposing ends (14 & 16) and a sealed interior (18). One end (14) having a movable shroud (24) and removable tab (22) for creating a drain vent and an opposing end (16) having a removable tab (30) for to create a drain vent.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.